Where to Buy NAD+: A Chair, a Prescription, or a Vial
Summary: NAD+ is unusual among the compounds this site covers because it has a real clinic channel and a real pharmacy channel alongside the research market. This page compares all five on what you actually receive, what it costs you in risk, and who has tested for endotoxins.
This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.
Where to buy NAD+ has five genuinely different answers, which is one more than most compounds get and two more than any research peptide. A clinic can put it in your arm today. A pharmacy can compound it against a prescription. A research supplier will ship you a gram of the powder. Those are not three versions of one transaction.
One of those five is the option this page can actually price, so it goes here rather than buried at the bottom.
Where readers actually buy it
Ascension Peptides — NAD+
Research-grade NAD+, tested by two outside labs and shipped from the US. The code below takes half off the vial.
Quoted per 100 mg because NAD+ is dosed in hundreds of milligrams, not the single milligrams a peptide vial holds. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.
- Batch certificates from two independent labs
- Free shipping over $250
- Ships same day if ordered before 2pm CST
Sold for laboratory research only and not for human consumption. These are affiliate links: we may earn a commission at no cost to you, and it does not change what we recommend. Prices checked August 20, 2026.
What is in the bag, and why it is not a GLP-1 story
NAD+ is nicotinamide adenine dinucleotide, a coenzyme rather than a drug. It is the electron carrier that moves reducing power through central metabolism, and the substrate that sirtuins, PARPs and CD38 consume as they work [5]. It is not a peptide, it has no sequence, and it is not an incretin. Nothing about it acts on the GLP-1 receptor.
Readers arrive here from our GLP-1 pages for one reason, which is fatigue in a calorie deficit, and NAD+ is marketed hard into exactly that feeling. So it is worth stating early that the human evidence is thin. The clearest study of infused NAD+ in people was a 2019 pilot whose authors pointed out that no data on the fate of directly infused NAD+ in a human cohort existed before them. Their finding was that plasma levels did not move for the first two hours of a six hour infusion because it was being cleared as it arrived [4]. That tells you something about disposition and nothing about benefit, and there is no efficacy trial standing behind the marketing.
Compare that with the compounds this site normally covers, where the argument is between two approved products with published endpoints, as in our guide to choosing between GLP-1 medications. NAD+ is not in that conversation. Buy accordingly.
Where to buy NAD+: the channels compared
| Channel | What you actually receive | Main risk | How the cost works |
|---|---|---|---|
| IV clinic or drip bar | An infusion prepared on site, administered by staff, usually over an hour or more | You rarely learn the grade or supplier of the raw material, and the FDA notice below is aimed squarely at this channel | Priced per session, often sold as packages or memberships, with the provider's time and facility in the price |
| 503A compounding pharmacy | A compounded preparation against a prescription, under FDA's interim category 1 policy | A compounded drug is not FDA-approved, and FDA does not verify its safety, effectiveness or quality before marketing | Prescription plus compounding fee, usually cash, rarely covered |
| Research supplier | A sealed vial of powder, labeled for laboratory use only, with batch certificates you can open | No regulator is checking, so every verification step is yours | Published per-vial price. The listing above is $52.00 for 1,000 mg with the code, which is $5.20 per 100 mg |
| Overseas marketplace | Sometimes the real compound, sometimes at real purity, on a multi-week journey | Customs exposure, no practical recourse, certificates often unmatched to your lot | Low headline price, high total cost when anything goes wrong |
| Supplement aisle | Not NAD+. Precursors, sold as dietary supplements | You may believe you bought the thing you searched for | Retail supplement pricing, and a different product |
The last row deserves a sentence rather than a shrug. Nicotinamide riboside and nicotinamide mononucleotide are NAD+ precursors, sold on supplement shelves, and they are not the same purchase as NAD+ itself. Their regulatory histories are separate from NAD's and we have not verified them, so this page will not summarise them. What we will say is that a bottle of precursor capsules is not an answer to a search for where to buy NAD+, whatever the shelf tag implies.
The clinic channel, and the warning written for it
The clinic route is the one people find first, because it advertises. It is also the channel FDA wrote to directly.
In a notice whose content is current as of 30 October 2024, FDA said it was aware of compounders using food-grade nicotinamide adenine dinucleotide sold by repackagers to make intravenous products, and that ingredients identified as food grade "are not suitable for compounding sterile drugs without appropriate processing, due to the high risk of contamination with microbes and endotoxins" [1]. It went on to report adverse event reports following use of NAD+ injectable drugs, including severe chills, shaking, vomiting and fatigue, with some requiring medical treatment, and stated these reactions were consistent with excessive levels of endotoxins [1].
That is not a warning about fake NAD+. It is a warning about correctly identified, adequately pure NAD+ that was made to a food standard and then infused. The relevant test is a bacterial endotoxins assay, and it is not the same test as the purity assay everyone publishes.
The other honest thing about this channel is that you are paying for administration. Pricing is structured per session, frequently sold in packages or as a membership, and the raw material is a small fraction of the ticket. We are not going to quote clinic figures we cannot source, so the arithmetic against a vial lives on our NAD+ price page where it can be shown properly, and the local search itself is taken apart on NAD+ near me.
The pharmacy channel, which genuinely exists here
This is where NAD+ separates from every research peptide this site has written about.
FDA's interim policy sorts substances nominated for use in 503A compounding into three categories. Nicotinamide Adenine Dinucleotide (NAD) is in Category 1, "Bulk Drug Substances Under Evaluation", along with the reduced disodium form, on the list updated May 14, 2026 [2]. Category 1 carries FDA's statement that it "does not intend to take action against a compounder for compounding drugs using bulk drug substances listed in category 1, provided that the conditions described in the guidance document are met" [2].
Say what that is and is not. It is non-enforcement while evaluation continues. It is not approval, and FDA notes substances can be removed from category 1 on safety information. Compare BPC-157, where no lawful prescription route opens at all, and the difference is real.
The catch is the one FDA states itself: compounded drugs are not FDA-approved, which means the agency does not verify their safety, effectiveness or quality before they are marketed [3]. A prescription gets you a pharmacist and a licensed facility. It does not get you the review process that stands behind a Wegovy pen.
There is also a naming trap here. Beta-Nicotinamide Adenine Dinucleotide Disodium Salt Trihydrate is a separate entry in Category 3, nominated without adequate support, and is not eligible for the category 1 policy [2]. Longer name, same words, different rules.
The research channel, where the checking is yours
The powder route is the only one where you can read the paperwork before you pay, which is its entire advantage and also the reason it demands more of you.
For the listing on this page: two independent laboratories publish batch certificates, Kovera Labs on lot 25-05260628 and MZ Biolabs on lot 25-01260229. The MZ Biolabs document reports 99.66% purity by HPLC-UV, identity confirmed by HPLC-MS, and a measured 784.32 mg per vial against the 1,000 mg label, with a note that salts and buffers added for solubility are not seen by UV and are not counted as impurities. Two named labs on lot-specific documents is above the norm for this market.
It also does not include a bacterial endotoxins line, and neither purity nor identity substitutes for one. That is the single question worth putting to any supplier in this channel, including this one, before an order rather than after. Our NAD+ where to buy checklist puts that criterion at the top for the same reason.
Overseas marketplaces
Packages do arrive. That is the honest part. Everything else about this channel tends to fail together: certificates that name no lot, or name a lot that is not yours, transit measured in weeks on material that should not spend weeks in transit, and no route to a refund from your jurisdiction. Import of an unapproved substance also puts the customs and regulatory exposure on you as the buyer, and we are not going to explain how to make a parcel less interesting to an inspector.
If the headline price is what drew you there, run the comparison properly. A gram at $52.00 domestic with two published certificates is not a premium product. It is the middle of the market with the paperwork attached.
Questions people ask about the channels
- Is buying NAD+ from a clinic safer than buying a vial?
- Not automatically. A clinic gives you trained administration and a room, which are real. It does not give you visibility of the raw material, and FDA's 2024 notice was about compounders using food-grade NAD+ sold by repackagers for intravenous products. Ask the grade and endotoxin questions in either channel.
- Can I get NAD+ on prescription?
- A 503A compounding pharmacy can prepare it under FDA's interim category 1 policy, so a prescription route exists in a way it does not for most research compounds. What you receive is a compounded drug, which FDA does not review for safety, effectiveness or quality before marketing.
- Are NMN and NR the same as buying NAD+?
- No. They are precursors sold as supplements. They have their own separate regulatory history which this page does not cover, and swallowing a precursor capsule is a different purchase from a gram of NAD+ in a vial.
- Does insurance cover any of this?
- Treat it as a cash purchase in every channel. Compounded preparations and wellness infusions are not the kind of thing insurers reimburse, and research material is not a medical purchase at all.
- Will NAD+ help with GLP-1 fatigue?
- There is no trial that shows that. Fatigue during rapid weight loss is common and has more boring explanations worth ruling out first, which our page on [GLP-1 fatigue](/side-effects/how-long-does-glp-1-fatigue-last/) goes through.
Where to buy NAD+ is really a question about which trade you want: convenience and a clinician with no visibility of the material, a prescription that buys process but not FDA review, or a vial where you can read every document and nobody is checking on your behalf. Pick the one whose weakness you can live with. If you would rather see the routes ranked by how much friction each one puts in front of you, how to get NAD+ does exactly that. NAD+ is unusual on this site in having a prescription route at all, and where there is no pharmacy channel for Selank in any form the map is shorter and the checking is entirely yours.
References
- FDA, FDA reminds compounders to use ingredients suitable for sterile compounding, content current as of 10/30/2024
- FDA, Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act, category lists updated May 14, 2026
- FDA, Compounding and the FDA: Questions and Answers
- Grant R et al, A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD, Frontiers in Aging Neuroscience 2019;11:257
- Covarrubias AJ, Perrone R, Grozio A, Verdin E, NAD+ metabolism and its roles in cellular processes during ageing, Nature Reviews Molecular Cell Biology 2021;22:119-141